Novo Nordisk Investors
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Headquarters:
Bagsværd
Number Of Exists:
4
Total Funding:
22000000
Founded Date:
1923-12-21
Acquisitions Number:
8.0
Employee Number:
64319
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Investor Type:
Undisclosed
Investors Number:
14
Last Funding Date:
2018-12-05 00:00:00
Technology:
Biotechnology, Health Care, Science and Engineering
Funding Status:
IPO
Estimated Revenue:
$1B to $10B
Industry:
End-to-End Drug Development